Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2025 Results: August 8, 2024

Rhea-AI Summary

Haemonetics (NYSE: HAE) announced it will publish its first quarter fiscal year 2025 financial results on August 8, 2024, at 6:00 am ET. The company has scheduled a conference call with investors and analysts at 8:00 am ET the same day to discuss the results and answer questions. Participants can access the call via teleconference upon registration, where they will receive a personalized PIN. It is recommended to join 10 minutes before the call starts. A live webcast will be available on Haemonetics' investor relations website, with a replay accessible for one year starting at 11:00 am ET on August 8, 2024.

Positive

• Haemonetics is proactively engaging with investors and analysts by scheduling a conference call to discuss Q1 FY 2025 financial results, indicating transparency and a commitment to stakeholder communication.

Negative

• None.

BOSTON, July 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, August 8, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on August 8, 2024.

The call can be accessed via teleconference at: Q1 2025 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/qeo7r49a 

A replay of the conference call and webcast will be available for one year beginning on August 8, 2024 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2025-results-august-8-2024-302191202.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics publish its Q1 FY 2025 financial results?

Haemonetics will publish its first quarter fiscal year 2025 financial results on August 8, 2024, at 6:00 am ET.

How can investors participate in Haemonetics' Q1 FY 2025 earnings call?

Investors can participate in the Q1 FY 2025 earnings call by registering for the teleconference, where they will receive a dial-in number and personalized PIN.

At what time is Haemonetics' Q1 FY 2025 earnings call scheduled?

The earnings call is scheduled for 8:00 am ET on August 8, 2024.

Where can the live webcast of Haemonetics' Q1 FY 2025 earnings call be accessed?

The live webcast can be accessed on Haemonetics' investor relations website.

How long will the replay of Haemonetics' Q1 FY 2025 earnings call be available?

The replay will be available for one year starting at 11:00 am ET on August 8, 2024.